Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1983 1
2016 1
2017 1
2018 2
2019 3
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Dendriform Pulmonary Ossification.
Anan K, Hisanaga J, Kawamura K, Ichikado K. Anan K, et al. Among authors: hisanaga j. Intern Med. 2019 Apr 1;58(7):1043-1044. doi: 10.2169/internalmedicine.1764-18. Epub 2018 Dec 18. Intern Med. 2019. PMID: 30568141 Free PMC article. No abstract available.
Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia.
Ichikado K, Kawamura K, Johkoh T, Fujimoto K, Shintani A, Hashimoto S, Eguchi Y, Yasuda Y, Anan K, Shingu N, Sakata Y, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nishiyama K, Nakamura K, Suga M, Ichiyasu H, Sakagami T. Ichikado K, et al. Among authors: hisanaga j. Sci Rep. 2021 Oct 8;11(1):20051. doi: 10.1038/s41598-021-99540-1. Sci Rep. 2021. PMID: 34625618 Free PMC article.
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment.
Sakata Y, Kawamura K, Ichikado K, Shingu N, Yasuda Y, Eguchi Y, Anan K, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nakano A, Sakagami T. Sakata Y, et al. Among authors: hisanaga j. Lung Cancer. 2019 Apr;130:159-161. doi: 10.1016/j.lungcan.2019.02.011. Epub 2019 Feb 14. Lung Cancer. 2019. PMID: 30885338
Comparisons between tumor burden and other prognostic factors that influence survival of patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Sakata Y, Kawamura K, Ichikado K, Shingu N, Yasuda Y, Eguchi Y, Hisanaga J, Nitawaki T, Iio M, Sekido Y, Nakano A, Sakagami T. Sakata Y, et al. Among authors: hisanaga j. Thorac Cancer. 2019 Dec;10(12):2259-2266. doi: 10.1111/1759-7714.13214. Epub 2019 Nov 3. Thorac Cancer. 2019. PMID: 31679185 Free PMC article.
Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
Hisanaga J, Kotani T, Fujiki Y, Yoshida S, Takeuchi T, Makino S. Hisanaga J, et al. Int J Rheum Dis. 2017 Dec;20(12):2182-2185. doi: 10.1111/1756-185X.13136. Epub 2017 Jul 27. Int J Rheum Dis. 2017. PMID: 28752606 No abstract available.